Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies
Novartis
Novartis
Novelty Nobility, Inc.
Deciphera Pharmaceuticals, LLC
Daiichi Sankyo
Pfizer
Novartis
Cantonal Hospital of St. Gallen
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Astellas Pharma Inc
National Cancer Institute (NCI)
NYU Langone Health
Case Comprehensive Cancer Center
FeRx